Novel C-seco-taxoids possessing high potency against paclitaxel-resistant cancer cell lines overexpressing class III beta-tubulin - Pepe, A; Sun, L; Zanardi, I; Wu, X; Ferlini, C; Fontana, G; Bombardelli, E; Ojima, I (Bioorg Med Chem Lett, 2009)